AQUALYX is an injectable treatment of 12alfa-dihydroxy-5beta-24-oico cholanic acid sodium salts, which is a modified compound of cholanic acid, rather than a simple solution of deoxycholate. This is a form of injection lipolysis, lipotherapy or intralipotherapy. It is marketed for aqualysis or aquaplasty treatment as a means of body contouring. Clinical data shows that the application of AQUALYX is effective and safe, leading to an increase in contoured appearance.

Characteristics

AQUALYX was developed to treat localised pockets of fat underneath the surface of the skin. It can be used to treat fat pockets on the back, chin, stomach, underneath the buttocks, hips, thighs and knees. It can also be used to treat pseudo-gynaecomastia, the development of fatty tissue around the nipple, resulting in a breast-like appearance in men (due to weight gain rather than the growth of actual breast tissue as seen in genuine male gynaecomastia). This is sometimes referred to as Motolese’s Solution.

AQUALYX was developed by Professor Pasquale Motolese, president of the Italian Society of Aesthetics and Medicine and was first introduced in 2009. Manufactured by the Italian firm Marllor, it was first launched in the UK in 2013 and is distributed in the UK by Healthxchange Pharmacy.

What is AQUALYX?

AQUALYX is an aqueous compound solution, with slow-release sugar that reduces the biological half-life of the solution, minimising side effects.

The ingredients are a polymer from 3, 6-Anhydro-L-Galactose and D-Galactose (0.5%), buffer systems (4.2%), sodium salt of (3, 5, 12) – 3, 12-dihydroxy-5-cholan-24-acid (7.5%), water for injection purposes (87%) and sodium chloride (0.8%).

The buffer system within AQUALYX ensures that the 12alfa-dihydroxy-5beta-24oico cholanic acid sodium salt is delivered to the target area.

Deoxycholic acid has been used in various fields of human medicine since its discovery. Present also in the human body, deoxycholic acid is used in the emulsification of fats for the absorption in the intestine.

How does it work?

The solution is injected into the treatment area whereby the 12alfa-dihydroxy-5beta-24-oico cholanic acid sodium salt of AQUALYX alters the surface tension of the fat cell membrane and increases the permeability of the membrane.

An ultrasound device is then applied over the surface of the skin in the targeted area and this causes the movement of liquids both inside and outside the fat cells.

The fat cells start to balloon and break up, leading to the drainage of micro droplets of fatty liquid into the body, which is then metabolised through the lymphatic system and excreted.

What happens during treatment?

One AQUALYX treatment typically consists of two injection sites.

A local anaesthetic, lidocaine, will usually be administered before the treatment commences. The practitioner may prefer however to add the lidocaine anaesthetic to the AQUALYX solution so that the two are injected together. Either method should minimise discomfort during the procedure.

The practitioner will use an ultrasound device in conjunction with the AQUALYX injections to assist in the dissipation of the fat cells.

Treatment regime: the time taken for a treatment session will depend upon the size of the area and indication being treated.

Treatment can take between 30 – 60 minutes per treatment and you will typically require 2 – 8 treatments, 4 weeks apart.

Some people may see significant results after 1 or 2 sessions.

Treatment for fat pockets underneath the neck and chin, for example, may require 1 – 3 treatments of 2 – 3 injections, while treatment for fat pockets on the hips and thighs may require 8 treatments.

Product Size:

5 x 8ml